Since we have demonstrated that H3K27me3 regulates the expression of NOTCH2 and modulates the sensitivity of CRC cells to the chemotherapeutic drug oxaliplatin, we hypothesized that the effect of H3K27me3 modification on drug sensitivity was likely due to its regulation on colorectal CSCs. This evidence concerns the gene NOTCH2 and colorectal carcinoma.